Sitemap
Epitopix Spotlight
bullet Epitopix receives USDA conditional license for America's first E. coli O157 vaccine for cattle
Epitopix receives USDA conditional license for America's first E. coli O157 vaccine for cattle
More

bullet 2008 Minnesota Dairy Health Conference
Larry M. Slinden, DVM, Epitopix presented at the 2008 Minnesota Dairy Health Conference.
More

bullet 2008 Beef Industry Safety Summit
Dr. Dan Thomson, Kansas State University will be presenting at the 2008 Beef Industry Safety Summit
More

bullet Cornell University Eighth Annual Fall Dairy Conference

Larry M. Slinden, DVM from Epitopix presented on "Salmonella's Effect on Performance in the Transition Cow" at the Eighth Annual Fall Dairy Conference at Cornell University, November 16-17, 2007.


More

bullet 16th Annual Alabama Conference for Food Animal Veterinarians
Larry M. Slinden, DVM, Epitopix partnered with AgriLabs in presenting SRP Technology in Food Animal Production at the 16th Annual Alabama Conference for Food Animal Veterinarians.
More

bullet ASM Conference - Salmonella: From Pathogenesis to Therapeutics
Dr. Daryll Emery presented at the ASM Conference in Victoria, BC, Canada September 9-13, 2006
More

bullet Academy of Veterinary Consultants Winter Conference

An Introduction to SRP Vaccine Technology

By:  Dr. Jim Sandstrom November 30, 2006 Denver, CO


More


ASM Conference - Salmonella: From Pathogenesis to Therapeutics Gray Dot
Gray Dot

Dr. Daryll Emery from Epitopix, LLC presents on Pre-Harvest Control of Salmonella Through Vaccination of Food Animals.  Salmonella enterica is a ubiquitous bacterium that is able to infect and colonize the intestinal mucosa of all animals in the human food chain and is considered to be amongst the most prevalent food borne pathogens on the planet.  The ability of Salmonella to evade host defenses and the emergence of antibiotic-resistant strains highlight the urgent need for developing improved strategies for the prevention and control of this pathogen.  Our investigations show that a composition of outer membrane proteins expressed by Salmonella in response to iron restriction constitutes an effective, safe and broad spectrum vaccine.  The studies demonstrate the efficacy of the vaccine in multiple farm animal species both under controlled laboratory conditions as well as in large commercial field trials with both systemic and oral homologous and heterologous challenge models.  Field and experiemental challenge studies in both domestic poultry and cattle show the vaccine to be highly efficacious in reducing morbidity/mortality and decreasing fecal shedding of numerous serotypes of Salmonella.  Taken together, the results of our studies suggest that administration of the vaccine to farm animals will not only reduce morbidity and mortality in livestock populations, but may also serve to reduce the transmission of Salmonella as a food borne pathogen to human populations.

blank